<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00921882</url>
  </required_header>
  <id_info>
    <org_study_id>07-084</org_study_id>
    <nct_id>NCT00921882</nct_id>
  </id_info>
  <brief_title>Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?</brief_title>
  <acronym>DG4</acronym>
  <official_title>Is it Possible to Screen for Type 2 Diabetes at Day 2 Gestational Diabetes Mellitus Postpartum?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Within 6 months of delivery, women who had gestational diabetes mellitus should be screened
      for type 2 diabetes with a fasting plasma glucose test and/or a 2-h postchallenge glycemia in
      a 75-g oral glucose tolerance test. However, not all women are screened. The objective of
      this study is to compare the screening test for type 2 diabetes done at 48 hours post-partum
      versus 8 weeks post-partum. The investigators want to measure the specificity, sensitivity,
      false and true predictive values of the screening test at 48 hours post-partum compared to
      the gold-standard.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2008</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oral glucose tolerance test</measure>
    <time_frame>8 weeks post partum</time_frame>
    <description>Sensitivity, specificity, true and false predictive values of the oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acceptability of screening test</measure>
    <time_frame>8 weeks post partum</time_frame>
    <description>Prefered moment to do the screening test (48 hours post partum or 8 weeks post partum)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Gestational Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <description>oral glucose tolerance test performed 48 hours post-partum and 8 weeks post-partum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oral glucose tolerance test</intervention_name>
    <description>Subjects will have the Oral glucose tolerance test 48 hours post-partum and the same test 8 weeks post-partum.</description>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with gestational diabetes mellitus who delivered.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dx of gestational diabetes treated with insulin

          -  To be in post-partum

          -  Delivery of a baby of at least 37 weeks of gestation

          -  Have signed the consent form

        Exclusion Criteria:

          -  History of glucose intolerance of diabetes before the pregnancy

          -  Obstetrical pathology during pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Ardilouze, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2009</study_first_submitted>
  <study_first_submitted_qc>June 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2009</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Jean-Luc Ardilouze</investigator_full_name>
    <investigator_title>Endocrinologist, researcher</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Post-partum screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

